OHR PHARMACEUTICAL INC - COM NEW (OHRP)

CUSIP: 67778H200

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM NEW
Total 13F shares
288,830
Share change
0
Total reported value
$2,275,000
Price per share
$7.88
Number of holders
14

Quarterly Holders Quick Answers

What is CUSIP 67778H200?
CUSIP 67778H200 identifies OHRP - OHR PHARMACEUTICAL INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OHR PHARMACEUTICAL INC - COM NEW (OHRP) as of Q4 2013

As of 31 Dec 2013, OHR PHARMACEUTICAL INC - COM NEW (OHRP) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 288,830 shares. The largest 10 holders included GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, PILLAR PACIFIC CAPITAL MANAGEMENT LLC, State Street Corp, PRICE T ROWE ASSOCIATES INC /MD/, FineMark National Bank & Trust, Tower Research Capital LLC, MORGAN STANLEY, and UBS AG. This page lists 14 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.